Gynecomastia laboratory findings

Revision as of 16:57, 17 October 2017 by Ajay Gade (talk | contribs)
Jump to navigation Jump to search

Gynecomastia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Gynecomastia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic study of choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Gynecomastia laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Gynecomastia laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Gynecomastia laboratory findings

CDC on Gynecomastia laboratory findings

Gynecomastia laboratory findings in the news

Blogs on Gynecomastia laboratory findings

Directions to Hospitals Treating Gynecomastia

Risk calculators and risk factors for Gynecomastia laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Husnain Shaukat, M.D [2]

Overview

Gynecomastia is diagnosed clinically after a thorough history and physical examination. Gynecomastia with recent onset and tender on the examination should have serum concentrations of human chorionic gonadotropin (hCG)LHtestosterone, and estradiol measured. The hormonal levels may vary depending on the underlying cause.

Laboratory Findings

References

  1. Braunstein GD (2007). "Clinical practice. Gynecomastia". N Engl J Med. 357 (12): 1229–37. doi:10.1056/NEJMcp070677. PMID 17881754.
  2. Rosner W, Auchus RJ, Azziz R, Sluss PM, Raff H (2007). "Position statement: Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement". J Clin Endocrinol Metab. 92 (2): 405–13. doi:10.1210/jc.2006-1864. PMID 17090633.
  3. Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR, Baltimore Longitudinal Study of Aging (2001). "Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging". J Clin Endocrinol Metab. 86 (2): 724–31. doi:10.1210/jcem.86.2.7219. PMID 11158037.
  4. Ismail AA, Astley P, Burr WA, Cawood M, Short F, Wakelin K; et al. (1986). "The role of testosterone measurement in the investigation of androgen disorders". Ann Clin Biochem. 23 ( Pt 2): 113–34. doi:10.1177/000456328602300201. PMID 3532913.

Template:WH Template:WS